My primary interest is stem cells, their capacity to repair the damaged brain, and to model human brain disorders. My lab helped prepare the first neural cell therapy to enter clinical trials in Europe. We subsequently used pluripotent stem cells to model neurodevelopmental disorders, particularly autism and schizophrenia. For two years I was Director of the UK Stem Cell bank, and promoted the use of human pluripotent stem cells for clinical use. I currently Head the Division of Advanced Therapies at the National Institute for Biological Standards and Control (NIBSC). I have published and spoken widely on Cell Therapies in both academic and popular formats. My book ‘The Future of Brain Repair: A Realist’s Guide to Stem Cell Therapy’ published by MIT Press will appear in March 2020.

Please see my Research Staff Profile for more detail

 

Find out more about my research:

• NIBSC Jack Price

Key publications:

• Pollock et al., 2006. A conditionally-immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Exp. Neurology.
• Kathuria et al., 2017.  iPSC-derived neurons from autistic individuals with SHANK3 mutation show morphogenetic deficits during early development. Molecular Psychiatry. 
• Price et al., 2017. Cellular recovery: How self-help could aid the damaged brain. New Scientist.

Key collaborators:

• Dr Elsa Abranches, National Institute for Biological Standards and Control
• Dr Deepak Srivastava, King's College London
• Dr Steve Pells, ReNeuron Ltd.
• Dr Christian Schneider, National Institute for Biological Standards and Control